Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

308
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
308
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets.

Nature cancer·2026
Same author

Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial.

Nature communications·2026
Same author

Bayesian adaptive randomization in the I-SPY2 sequential multiple assignment randomized trial.

Biometrics·2026
Same author

Explainable machine learning prediction of functional independence measure scores and gain in subacute stroke survivors.

Journal of neuroengineering and rehabilitation·2026
Same author

N-propargylglycine restores survival by preventing calcium oxalate stone formation, tubular injury, and kidney dysfunction in a lethal mouse model of primary hyperoxaluria type 2.

Kidney international·2026
Same author

Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer.

NPJ precision oncology·2026
Same journal

Protocol for genomic mapping of chromatin targets using high-throughput CUT&RUN.

STAR protocols·2026
Same journal

A protocol for noninvasive quantification of dietary fat absorption in mice.

STAR protocols·2026
Same journal

Protocol for an AlCl<sub>3</sub>-induced Alzheimer's model in zebrafish larvae with optimized pH and behavioral assessment.

STAR protocols·2026
Same journal

Protocol for live cell barcoding and immunophenotyping of human hematological malignancies using cytometry by time of flight.

STAR protocols·2026
Same journal

Generating drug resistance models in human and murine cancer cell lines and assessing cross-resistance to chemotherapeutics and KRAS inhibitors.

STAR protocols·2026
Same journal

Protocol for simultaneous in vivo two-photon imaging and locomotion quantification during olfactory stimulation and pharmacology in walking Drosophila.

STAR protocols·2026
See all related articles

Related Experiment Video

Updated: May 15, 2025

Using SCOPE to Identify Potential Regulatory Motifs in Coregulated Genes
07:55

Using SCOPE to Identify Potential Regulatory Motifs in Coregulated Genes

Published on: May 31, 2011

10.3K

Protocol for obtaining cancer type and subtype predictions using subSCOPE.

Jasleen K Grewal1, A Gordon Robertson1, Kyle Ellrott2

  • 1Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4S6, Canada.

STAR Protocols
|April 9, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces subSCOPE, a machine learning protocol for predicting cancer types and subtypes using multi-omics data. It classifies non-TCGA cancer samples into 106 subtypes across 26 cancer cohorts.

Keywords:
BioinformaticsCancerComputer sciencesGenomics

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

185
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.4K

Related Experiment Videos

Last Updated: May 15, 2025

Using SCOPE to Identify Potential Regulatory Motifs in Coregulated Genes
07:55

Using SCOPE to Identify Potential Regulatory Motifs in Coregulated Genes

Published on: May 31, 2011

10.3K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

185
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

19.4K

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Genomics

Background:

  • Accurate cancer subtyping is crucial for personalized treatment and understanding tumor heterogeneity.
  • Existing methods may not fully leverage the potential of multi-omics data for precise classification.

Purpose of the Study:

  • To present a standardized protocol for cancer type and subtype prediction using the subSCOPE machine learning method.
  • To enable classification of diverse cancer samples using multiple omics data types.

Main Methods:

  • The protocol details data preparation, subSCOPE setup, and inference execution.
  • It integrates five omics data types: DNA methylation, gene expression, microRNA expression, point mutations, and copy-number variants.
  • Supports individual selection of cancer types and data modalities.

Main Results:

  • The subSCOPE protocol facilitates subtype-level classification for non-TCGA cancer samples.
  • It achieves classification across 26 The Cancer Genome Atlas (TCGA) cancer cohorts and 106 distinct subtypes.
  • Demonstrates a flexible framework for leveraging multi-omics data in cancer research.

Conclusions:

  • The presented protocol offers a robust and adaptable tool for cancer subtyping using machine learning and multi-omics data.
  • It enhances the ability to classify cancer subtypes, particularly for samples outside of large public datasets like TCGA.
  • Facilitates deeper insights into cancer biology and supports the development of targeted therapies.